19th Jul 2021 21:48
MaxCyte Inc - cell-engineering platform technologies provider - Reports mechanical and administrative matters in relation to its proposed dual-listing on the Nasdaq Global Market and planned public offering of shares in the US. The company intends to appoint Computershare Trust Co NA to act as its US transfer agent. In addition, in order to ensure ease of cross-border movements of shares between the UK and US markets for stockholders, MaxCyte has arranged for the current depositary interests issued by Link Market Services Trustees Ltd to be replaced with CREST depository interests. The company has arranged with the depositary for the current depositary interests facility to be terminated with effect from July 28. In anticipation of this change, stock deposits and withdrawals will not be possible in CREST from July 26.
Current stock price: 1,053.00 pence, closed down 2.1% on Monday
Year-to-date change: almost doubled from 527.50p on December 31, 2020
By Evelina Grecenko; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
MaxCyte